Dr. David Perlmutter
speaker
551 appearances
1 recordings
1 series
first heard Jul 2026
last heard 9 Jul
Dr. David Perlmutter’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
And mitochondrial transplantation.
Mitochondrial transplantation already, you know, is being refined, but this microglial transplantation where people are receiving embryonic pluripotential uh that that have then become microglial cells, they're getting those by injection after their bone marrow has.
been wiped out uh with with uh something called ALSP, which is not ALS, it's a it's a leucone cephalopathy, uh a white matter disease of the brain.
But they they it's uniformly fatal.
And now they've arrested that disease by doing this process.
That's where what's on is on the horizon.
But I'm very pleased that people are backing away from this silly amyloid hypothesis.
And and I don't know if I've called it on any other podcast silly, but now that I think about it, it's uh No, I mean I I'm just gonna call it as I see it.
It's ridiculous.
Uh when when the first drug monoclonal antibody was developed to get rid of the amyloid as a treatment for Alzheimer's, it was put before the FDA.
There was a panel of twelve.
One person voted for it, one person was saying, and the rest, the ten people voted no, you cannot approve this drug.
Because the patients didn't improve and they didn't even slow their decline.
It doesn't work.
It doesn't work.
Then the drug manufacturer went back and said, doesn't have any effect on cognitive function.
I know.
Let's see if we can get it approved for getting rid of beta amyloid in the brain, because as we all know, that's the cause of Alzheimer's.
And it it does help lower the burden of beta amyloid in the brain.
Hence, it got approved.
Showing 441–460 of 551 · page 23 of 28
← Previous
Next →